The bill amends and reenacts R.S. 22:1028.5(D) and enacts R.S. 22:1028.5(F) to enhance coverage for biomarker testing in Louisiana. It mandates that health coverage plans provide coverage for biomarker tests without imposing conditions based on laboratory classifications or credentialing standards that are unrelated to the performance of the tests. This aims to ensure that patients experience minimal disruptions in care, such as the need for multiple biopsies or biospecimen samples.

Additionally, the new provision in R.S. 22:1028.5(F) establishes that in cases of conflict between this section and R.S. 22:1028.3, the provisions of this bill will take precedence. The bill is set to take effect upon the governor's signature or after the designated period for bills to become law without a signature, ensuring timely implementation of these important healthcare provisions.

Statutes affected:
SB169 Original: 22:5(D)
SB169 Engrossed: 22:5(D)
SB169 Enrolled: 22:5(D)
SB169 Act 469: 22:5(D)